Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2009

01-03-2009 | Epidemiology

Changes in quality of life among breast cancer patients three years post-diagnosis

Authors: Wei Lu, Yong Cui, Xiaoli Chen, Ying Zheng, Kai Gu, Hui Cai, Wei Zheng, Xiao-Ou Shu

Published in: Breast Cancer Research and Treatment | Issue 2/2009

Login to get access

Abstract

Objectives To evaluate changes in quality of life (QOL) and identify medical and socio-demographic predictors of QOL among breast cancer survivors 3 years after diagnosis. Methods Between April 2002 and March 2004 2,232 women with breast cancer were recruited into the Shanghai Breast Cancer Survival Study, a population-based cohort study, approximately 6 months after cancer diagnosis. QOL was evaluated at 6 and 36 months post-diagnosis using the General Quality of Life Inventory. Multiple linear regression models were used to evaluate changes in QOL and their associations with socio-demographic and medical factors. Results In general, breast cancer patients showed significant improvement over time in the physical, psychological, and social well-being domains, as well as overall QOL. However, QOL scores in several facets did not improve or even deteriorated, including increased negative feelings, reduced social support and interpersonal relationships, and worsened financial situation and living environment. Age at diagnosis was inversely associated with QOL changes in physical and psychological well-being and overall QOL scores. Compared with those who were disease-free, patients with a recurrence of disease had significantly poorer QOL scores across all well-being domains and almost all facets. Patients who received radiotherapy experienced significant improvements in physical and social well-being and overall QOL. Mixed ER/PR status was associated with improved scores in physical and psychological well-being and overall QOL. Education, body mass index, Charlson comorbidity score, TNM stage, type of surgery, chemotherapy, and immunotherapy were only associated with changes in certain well-being domains and/or facets, but not overall QOL. Tamoxifen use was not associated with changes in QOL outcomes. Conclusions Our study provides valuable information for developing strategies/interventions for improving the QOL of breast cancer patients.
Literature
1.
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef
2.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66PubMedCrossRef
3.
Fallowfield L (2002) Quality of life: a new perspective for cancer patients. Nat Rev Cancer 2:873–879PubMedCrossRef
4.
Sun CC, Frumovitz M, Bodurka DC (2005) Quality of life and gynecologic malignancies. Curr Oncol Rep 7(6):459–465PubMedCrossRef
5.
American Society of Clinical Oncology Outcomes Working Group (1996) Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14:671–679
6.
Movsas B (2003) Quality of life in oncology trials: a clinical guide. Semin Radiat Oncol 13:235–247PubMedCrossRef
7.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe RB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef
8.
Ferrell BR, Grant M, Funk B, Otis-Green S, Garcia N (1997) Quality of life in breast cancer. Part I: physical and social well-being. Cancer Nurs 20:398–408PubMedCrossRef
9.
Ferrell BR, Grant M, Funk B, Otis-Green S, Garcia N (1998) Quality of life in breast cancer. Part II: psychological and spiritual well-being. Cancer Nurs 21:1–9PubMedCrossRef
10.
11.
12.
Bloom JR, Petersen DM, Kang SH (2007) Multi-dimensional quality of life among long-term (5+ years) adult cancer survivors. Psychooncology 16:691–706PubMedCrossRef
13.
Bloom JR, Stewart SL, Chang S, Banks PJ (2004) Then and now: quality of life of young breast cancer survivors. Psychooncology 13:147–160PubMedCrossRef
14.
Dorval M, Maunsell E, Deschenes L, Brisson J (1998) Type of mastectomy and quality of life for long term breast carcinoma survivors. Cancer 83:2130–2138PubMedCrossRef
15.
Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94:39–49PubMed
16.
Helgeson VS, Tomich PL (2005) Surviving cancer: a comparison of 5-year disease-free breast cancer survivors with healthy women. Psychooncology 14:307–317PubMedCrossRef
17.
Kendall AR, Mahue-Giangreco M, Carpenter CL, Ganz PA, Bernstein L (2005) Influence of exercise activity on quality of life in long-term breast cancer survivors. Qual Life Res 14:361–371PubMedCrossRef
18.
Helgeson VS, Snyder P, Seltman H (2004) Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychol 23:3–15PubMedCrossRef
19.
20.
Yang L, Parkin DM, Ferlay J, Li L, Chen Y (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14:243–250PubMedCrossRef
21.
Cui Y, Shu XO, Gao Y, Cai H, Wen W, Ruan ZX, Jin F, Zheng W (2004) The long-term impact of medical and socio-demographic factors on the quality of life of breast cancer survivors among Chinese women. Breast Cancer Res Treat 87:135–147PubMedCrossRef
22.
Lu W, Cui Y, Zheng Y, Gu K, Cai H, Li Q, Zheng W, Shu XO (2007) Impact of newly diagnosed breast cancer on quality of life among Chinese women. Breast Cancer Res Treat 102:201–210PubMedCrossRef
23.
Nuttall M, van der Meulen J, Emberton M (2006) Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol 59(3):265–273PubMedCrossRef
24.
Grunau GL, Sheps S, Goldner EM, Ratner PA (2006) Specific comorbidity risk adjustment was a better predictor of 5-year acute myocardial infarction mortality than general methods. J Clin Epidemiol 59(3):274–280PubMedCrossRef
25.
Department of Health, Human Services (1998) The international classification of diseases. 9th rev. edn. Clinical modification, ICD-9-CM. U.S. Government Printing Office, Washington, DC
26.
Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L (1996) Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res Treat 38:183–199PubMedCrossRef
27.
Shimozuma K, Ganz PA, Petersen L, Hirji K (1999) Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer Res Treat 56:45–57PubMedCrossRef
28.
Janz NK, Mujahid M, Lantz PM, Fagerlin A, Salem B, Morrow M, Deapen D, Katz SJ (2005) Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer. Qual Life Res 14:1467–1479PubMedCrossRef
29.
Bull AA, Meyerowitz BE, Hart S, Mosconi P, Apolone G, Liberati A (1999) Quality of life in women with recurrent breast cancer. Breast Cancer Res Treat 54:47–57PubMedCrossRef
30.
Frost MH, Suman VJ, Rummans TA, Dose AM, Taylor M, Novotny P, Johnson R, Evans RE (2000) Physical, psychological and social we-being of women with breast cancer: the influence of disease phase. Psychooncology 9:221–231CrossRef
31.
Oh S, Heflin L, Meyerowitz BE, Desmond KA, Rowland JH, Ganz PA (2004) Quality of life of breast cancer survivors after a recurrence: a follow-up study. Breast Cancer Res Treat 87:45–57PubMedCrossRef
32.
Northouse LL, Mood D, Kershaw T, Schafenacker A, Mellon S, Walker J, Galvin E, Decker V (2002) Quality of life of women with recurrent breast cancer and their family members. J Clin Oncol 20:4050–4064PubMedCrossRef
33.
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef
34.
Poggi MM, Danforth DN, Sciuto LC, Smith SL, Steinberg SM, Liewehr DJ, Menard C, Lippman ME, Lichter AS, Altemus RM (2003) Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 98:697–702PubMedCrossRef
35.
Janni W, Rjosk D, Dimpfl TH, Haertl K, Strobl B, Hepp F, Hanke A, Bergauer F, Sommer H (2001) Quality of life influenced by primary surgical treatment for stage I–III breast cancer-long-term follow-up of a matched-pair analysis. Ann Surg Oncol 8:542–548PubMed
36.
Rowland JH, Desmond KA, Meyerowitz BE, Belin TR, Wyatt GE, Ganz PA (2000) Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst 92:1422–1429PubMedCrossRef
37.
Parker PA, Youssef A, Walker S, Basen-Engquist K, Cohen L, Gritz ER, Wei QX, Robb GL (2007) Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancer. Ann Surg Oncol 14:3078–3089PubMedCrossRef
38.
Moyer A (1997) Psychosocial outcomes of breast-conserving surgery versus mastectomy: a meta-analytic review. Health Psychol 16:284–298PubMedCrossRef
39.
Nissen MJ, Swenson KK, Ritz LJ, Farrell JB, Sladek ML, Lally RM (2001) Quality of life after breast carcinoma surgery: a comparison of three surgical procedures. Cancer 91:1238–1246PubMedCrossRef
40.
Ganz PA, Schag AC, Lee JJ, Polinsky ML, Tan SJ (1992) Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer 69:1729–1738PubMedCrossRef
41.
Kagawa-Singer M, Wellisch DK, Durvasula R (1997) Impact of breast cancer on Asian American and Anglo American women. Cult Med Psychiatry 21:449–480PubMedCrossRef
42.
Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ Jr, Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D (2001) National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1–3, 2000. J Natl Cancer Inst 93:979–989PubMedCrossRef
43.
Janz NK, Mujahid M, Chung LK, Lantz PM, Hawley ST, Morrow M, Schwartz K, Katz SJ (2007) Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt) 16:1348–1361CrossRef
44.
Hickok JT, Morrow GR, Roscoe JA, Mustian K, Okunieff P (2005) Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage 30:433–442PubMedCrossRef
45.
Whelan TJ, Levine M, Julian J, Kirkbride P, Skingley P (2000) The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial Ontario Clinical Oncology Group. Cancer 88:2260–2266PubMedCrossRef
46.
Early Breast Cancer Trialists’ Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351:1451–1467CrossRef
47.
Whelan TJ, Pritchard KI (2006) Managing patients on endocrine therapy: focus on quality-of-life issues. Clin Cancer Res 12:1056–1060CrossRef
48.
Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A (2004) Quality of life of postmenopausal women in the arimidex, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial. J Clin Oncol 22:4261–4271PubMedCrossRef
49.
Fallowfield LJ, Bliss JM, Porter LS, Price MH, Snowdon CF, Jones SE, Coombes RC, Hall E (2006) Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. J Clin Oncol 24:910–917PubMedCrossRef
50.
Vacek PM, Winstead-Fry P, Secker-Walker RH, Hooper GJ, Plante DA (2003) Factors influcing quality of life in breast cancer survivors. Qual Life Res 12:527–537PubMedCrossRef
51.
Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Holzel D (2003) Predictors of quality of life pf breast cancer patients. Acta Oncol 42:710–718PubMedCrossRef
52.
Härtl K, Janni W, Kästner R, Sommer H, Strobl B, Rack B, Stauber M (2003) Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients. Ann Oncol 14:1064–1071PubMedCrossRef
53.
Browall MM, Ahlberg KM, Persson LO, Karlsson PO, Danielson EB (2008) The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy. Acta Oncol 47(2):207–215PubMedCrossRef
54.
Fehlauer F, Tribius S, Mehnert A, Rades D (2005) Health-related quality of life in long term breast cancer survivors treated with breast conserving therapy: impact of age at therapy. Breast Cancer Res Treat 92:217–222PubMedCrossRef
Metadata
Title
Changes in quality of life among breast cancer patients three years post-diagnosis
Authors
Wei Lu
Yong Cui
Xiaoli Chen
Ying Zheng
Kai Gu
Hui Cai
Wei Zheng
Xiao-Ou Shu
Publication date
01-03-2009
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2009
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0008-3

Other articles of this Issue 2/2009

Breast Cancer Research and Treatment 2/2009 Go to the issue

Preclinical Study

Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation

Preclinical Study

Molecular profiles of progesterone receptor loss in human breast tumors

Preclinical study

Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant

Clinical Trial

Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence

Review

Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer

Brief Report

Effect of Coenzyme Q10, Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits